Aetna Inc. (AET) Position Boosted by Sabal Trust CO
Sabal Trust CO boosted its stake in Aetna Inc. (NYSE:AET) by 0.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,004 shares of the company’s stock after buying an additional 4 shares during the period. Sabal Trust CO’s holdings in Aetna were worth $1,823,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. BlackRock Inc. raised its position in shares of Aetna by 3,374.9% in the first quarter. BlackRock Inc. now owns 30,712,219 shares of the company’s stock worth $3,917,344,000 after buying an additional 29,828,390 shares during the period. Vanguard Group Inc. raised its position in shares of Aetna by 3.8% in the first quarter. Vanguard Group Inc. now owns 23,117,526 shares of the company’s stock worth $2,948,640,000 after buying an additional 838,578 shares during the period. FMR LLC raised its position in shares of Aetna by 2.2% in the first quarter. FMR LLC now owns 7,903,233 shares of the company’s stock worth $1,008,059,000 after buying an additional 167,261 shares during the period. Bank of New York Mellon Corp raised its position in shares of Aetna by 3.9% in the first quarter. Bank of New York Mellon Corp now owns 4,378,982 shares of the company’s stock worth $558,540,000 after buying an additional 165,278 shares during the period. Finally, Dimensional Fund Advisors LP raised its position in shares of Aetna by 0.6% in the first quarter. Dimensional Fund Advisors LP now owns 3,962,514 shares of the company’s stock worth $505,399,000 after buying an additional 21,953 shares during the period. Institutional investors own 91.73% of the company’s stock.
Shares of Aetna Inc. (NYSE:AET) traded up 0.13% during trading on Monday, reaching $156.99. 1,283,443 shares of the company traded hands. The firm’s 50-day moving average is $153.22 and its 200-day moving average is $137.42. Aetna Inc. has a 12-month low of $104.59 and a 12-month high of $157.79. The stock has a market capitalization of $52.07 billion, a PE ratio of 47.88 and a beta of 0.54.
Aetna (NYSE:AET) last issued its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, beating the consensus estimate of $2.34 by $1.08. The company had revenue of $15.52 billion during the quarter, compared to analysts’ expectations of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. Aetna’s revenue for the quarter was down 2.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.21 earnings per share. On average, equities analysts predict that Aetna Inc. will post $9.38 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Investors of record on Thursday, July 13th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, July 11th. This represents a $2.00 annualized dividend and a yield of 1.27%. Aetna’s dividend payout ratio is currently 43.67%.
TRADEMARK VIOLATION WARNING: “Aetna Inc. (AET) Position Boosted by Sabal Trust CO” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international trademark and copyright law. The original version of this piece of content can be read at https://www.thecerbatgem.com/2017/08/07/sabal-trust-co-acquires-4-shares-of-aetna-inc-aet-updated.html.
AET has been the topic of a number of research reports. Cowen and Company set a $170.00 price target on shares of Aetna and gave the company a “buy” rating in a research note on Saturday, May 27th. Credit Suisse Group reiterated a “buy” rating and issued a $155.00 price target on shares of Aetna in a research note on Wednesday, May 17th. UBS AG restated a “buy” rating and set a $160.00 target price (up previously from $147.00) on shares of Aetna in a research report on Wednesday, May 17th. Bank of America Corporation restated a “buy” rating and set a $168.00 target price (up previously from $160.00) on shares of Aetna in a research report on Wednesday, May 17th. Finally, Stifel Nicolaus increased their target price on shares of Aetna from $150.00 to $158.00 and gave the stock a “buy” rating in a research report on Tuesday, May 16th. Eight equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $155.78.
In other Aetna news, Chairman Mark T. Bertolini sold 103,547 shares of the business’s stock in a transaction that occurred on Wednesday, May 17th. The shares were sold at an average price of $140.79, for a total value of $14,578,382.13. Following the completion of the transaction, the chairman now owns 659,888 shares of the company’s stock, valued at approximately $92,905,631.52. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Margaret M. Mccarthy sold 27,028 shares of the business’s stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the completion of the transaction, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,008,606.49. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.